Information Library
Results for: Hear From the Experts - Phase I/IIa
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio
January 16, 2012
This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies. -
Harish Dave Discusses ASH 2011
December 8, 2011
Harish Dave discusses the American Society of Hematology annual meeting. -
The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio
December 6, 2011
This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies. -
Exclusive Report From Scientific American
November 9, 2010
In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today. -
Healthcare's Future Tools
November 8, 2010
Beyond Genomics. The knowledge gained in mapping the genome is producing more tools and new ways of understanding how the human body works. See what's in store in this exclusive report. -
Applications of Modeling and Simulation in Cardiac Safety Studies
May 27, 2010
Applications of Modeling and Simulation is discussed by Giridhar S. Tirucherai PhD, Director, Clinical PK-PD at Quintiles in the April issue of DIA Global Forum. -
Assessing Cardiac Safety Throughout Clinical Development
May 27, 2010
Assessing Cardiac Safety Throughout Clinical Development and the ramifications for an integrated cardiac safety program is discussed by Rick Turner, Senior Scientific Director at Quintiles in the April issue of DIA Global Forum. -
Podcast: Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Podcast: Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development.
Page 1 of 1 (9 results)
